Playing it safe at every stage of the printing process: we produce leaflets in offset or digital. Defective, one-sided printed leaflets are excluded from the outset.
Package insert printing Germany - flat or folded?
It depends on your packaging line! Our packaging experts have been working with the industry for decades. The folds of the lightweight papers are as varied as the demands of our customers.
as the demands of our customers. Hardly any package inserts have the same format. We can realise up to 10 parallel folds and 3 cross folds and produce individually for you, from small to large runs.
from small to large print runs. Experience and know-how in printing leaflets and package inserts are what set us apart.
Instruction leaflet or package insert - both! An instruction leaflet is enclosed with finished medicinal products as a package insert. The consumer can provide the package leaflet with all the important information
e.g. about the correct intake and use, the recommended dosage, but also about the possible side effects or dangers associated with taking and using the product.
of the drug. The patient information leaflet is often also called patient information or instructions for use, in the vernacular or colloquial sometimes also "wash note". In the
In most countries, such an instruction leaflet is mandatory as a package insert. In the EU there are guidelines and requirements regarding the use and application of the package leaflet.
Pharmaceutical manufacturers know the necessary specifications - we produce and print efficiently on lightweight papers with multiple parallel and cross breaks.
Package insert printing Germany we print for the pharmaceutical industry on thin printing paper.
Thin paper: We print package inserts, instructions for use and operating instructions for the industry on thin paper. Whether obligatory information, which is required by the legislator for medicines
to the description of technical devices, to the correct operation of a product / a device. Consumer information serves the technical documentation, the explanation
explanation of the functionality or contain information on the correct operation or maintenance of products. We offer our industrial customers security and perfection in the
production and printing of leaflets. We are one of the leading manufacturers in this segment for Germany, Austria and Switzerland and beyond throughout Europe.
With production sites in Austria / Vorarlberg and Germany we offer reliable and certified print production for any size of company and industry. Package insert printing
and further processing, even of very large quantities, are among our strengths. As an industrial customer, you can benefit from our well thought-out and process-optimised production of
products in compliance with even the strictest safety standards. Ultimately, what counts is: cost-optimised production, transparent communication, adherence to delivery times and deadlines.
Characteristics of an instruction leaflet.
The package insert often contains the following topics: "Characteristics of the medicinal product", pharmaceutical form, pharmaceutical-therapeutic class, areas of application, contraindications,
Precautions, interactions with other substances such as alcohol or tobacco, general warnings, dosing, risk groups, side effects, ingredients.
Must the BBD - the best-before date - be included on the package insert?
The BBD - Best before date - is usually printed or embossed on the packaging itself. Thus, after the release of the drug by the corresponding
The "Best before date" is completed inline in the production line and the "Best before date" is also added to.
Advertising information on an instruction leaflet?
The package leaflet must not contain any promotional information or information of an advertising nature. Formal design specifications contain corresponding guidelines of the EU Commission. These range from
Recommendations about minimum font size, contrast or line spacing, but also limitations: Small caps (capital letters), for example, as well as illustrations in the text are to be used as far as possible.
for the time being. There are also standardized terms about the frequency or rarity specifically of side effects. The term "very frequent" means, for example, more than 10% of those treated.
On the other hand, "very rare" means that less than one patient in 10,000 has this side effect.
Formal design specifications for a package insert in DE/AT/CH.
In Germany, Austria and Switzerland, these guidelines are regulated by corresponding drug laws. Each country has its own specific requirements, which are set out in an instruction leaflet, must be fulfilled. Studies on comprehensibility, comprehensibility of side-effect risks and legibility round off the requirements.